Stem Cells & Ai In Drug Discovery: Ipscs And Organoids 101

Learn how stem cells, iPSCs, organoids, and AI are transforming clinical trials, drug safety, and personalized medicine.

What you'll learn

Describe how iPSCs are generated and applied in drug discovery and regenerative medicine.

Explain how AI accelerates drug screening, toxicity prediction, and personalized therapy.

Evaluate the limitations of traditional drug development and benefits of clinical trials in a dish.

Identify how lab-grown organoids and patient-derived cells improve disease modeling.

Requirements

No prior experience needed. A curiosity for medicine, biotech, or AI is all you need.

Description

Are you curious about how the future of drug discovery is shifting toward patient-specific, human-relevant systems? This course introduces you to the cutting-edge intersection of iPSC technology, AI, and organoids that is redefining biomedical research.You will learn how induced pluripotent stem cells, or iPSCs, are generated from adult somatic cells using Yamanaka factors, and how they can be differentiated into functional, organ-specific tissues. These lab-grown tissues, known as organoids, are already being used in clinical trials in a dish to predict drug responses with far greater accuracy than animal models.We will also explore how artificial intelligence is revolutionizing safety assessment, drug screening, and personalized medicine. Key topics include the FDA Modernization Act 2.0, preclinical safety pipelines, biobanking, and case studies in cardiology, oncology, and neurodegenerative disease research.This course is ideal for students, pre-med learners, biotech professionals, and anyone passionate about the future of translational science. No prior lab experience required — just curiosity and a drive to understand the future of precision medicine.What you will learn:iPSC generation, differentiation, and therapeutic applicationsOrganoid models and their role in preclinical testingAI-driven approaches in drug developmentEthical, regulatory, and safety frameworks in next-gen therapeuticsJoin us and become fluent in the science behind tomorrow's medicine.

Overview

Section 1: The Drug Discovery Crisis and the Rise of Stem Cell Technologies

Lecture 1 Lecture 1.1 – Why 90% of Drugs Fail: A Crisis in Drug Discovery

Lecture 2 Lecture 1.2 – Cellular Reprogramming: Turning Adult Cells Into Stem Cells

Lecture 3 Lecture 1.3 – Mini-Organs in a Dish: A New Frontier in Testing Drugs

Section 2: Patient-Specific Models and the Science of Cell Therapy

Lecture 4 Lecture 2.1 – Using Patient iPSCs to Study Disease and Test Therapies

Lecture 5 Lecture 2.2 – The Cell Therapy Journey: What Happens After Transplant?

Lecture 6 2.3 – Testing Cell Therapy Safety: Tumor Risk, Toxicity & cGMP

Section 3: The Future of Personalized, Ethical, and AI-Driven Medicine

Lecture 7 Lecture 3.1 – AI in Drug Discovery: Faster, Smarter, More Precise

Lecture 8 3.2 – Your Cells, Your Medicine: Personalized Treatment Begins Here

Lecture 9 Lecture 3.3 – Beyond Animal Testing: A New Era in Ethical Drug Discovery

This course is perfect for biology or medical students, early-career researchers, tech enthusiasts, and anyone curious about the future of drug discovery, AI, and stem cell science.